Two Sigma Investments, LP Orchard Therapeutics PLC Transaction History

Two Sigma Investments, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.36 - $0.49 $5,286 - $7,196	-14,686 Reduced 40.14%	21,905 $8,000
Q3 2022 Nov 14, 2022	BUY	$0.45 - $0.69 $7,450 - $11,423	16,556 Added 82.64%	36,591 $18,000
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.78 $8,414 - $15,627	20,035 New	20,035 $12,000
Q1 2022 May 16, 2022	SELL	$0.7 - $1.51 $379,548 - $818,740	-542,212 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.23 $628,965 - $1.21 Million	542,212 New	542,212 $716,000
Q2 2021 Aug 16, 2021	SELL	$4.39 - $7.23 $86,408 - $142,308	-19,683 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.39 - $9.08 $325,953 - $674,180	-74,249 Reduced 79.05%	19,683 $143,000
Q4 2020 Feb 16, 2021	BUY	$3.86 - $5.07 $362,577 - $476,235	93,932 New	93,932 $406,000
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $299,010 - $469,250	-72,752 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.75 - $11.99 $113,487 - $236,646	19,737 Added 37.23%	72,752 $437,000
Q1 2020 May 15, 2020	BUY	$5.65 - $15.71 $177,003 - $492,162	31,328 Added 144.46%	53,015 $399,000
Q4 2019 Feb 14, 2020	BUY	$10.15 - $15.58 $220,123 - $337,883	21,687 New	21,687 $298,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.